Home / Markets / News / Nifty Pharma index hits new high; Aurobindo, Dr Reddy's gain over 3%

Nifty Pharma index hits new high; Aurobindo, Dr Reddy's gain over 3%

Marksans Pharma and Novartis India from the S&P BSE Healthcare index zoomed 20 per cent each

vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab

Premium

2 min read Last Updated : Jun 11 2021 | 3:10 PM IST

Shares of pharmaceutical companies continued their upward journey at the bourses, with the Nifty Pharma index hitting a new high for the third straight day on Friday, amid strong gain in Aurobindo Phamra, Dr Reddy’s Laboratories and Cadila Healthcare, which rallied up to 5 per cent, each, on the National Stock Exchange (NSE).

Nifty Pharma index rallied 3 per cent to 14,530.95 on the NSE in intra-day trade today. On Wednesday, it had surpassed its previous high of 14,282.90, touched on May 11, 2021.

Marksans Pharma and Novartis India from the S&P BSE Healthcare index zoomed 20 per

Topics : Nifty Pharma Buzzing stocks Markets Aurobindo Pharma Marksans Pharma Thyrocare Technologies

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in